Contact

Representative before the EPO

Company dna urquhart dykes and lord llp
no operation time available
8 offices
active in Legal Services

We have observed 51 EP applications Simon James Mitchell has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after November 19, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12831918

RILPIVIRINE HYDROCHLORIDE

IPC classification:
C07D 239/48
Applicant:
Hetero Research Foundation
Agent:
Michael Best, Lederer Keller Patentanwälte Partnerschaft mbB
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION IN PROGRESS
EP12836162

NOVEL SALTS OF ALOGLIPTIN

IPC classification:
C07D 401/04
Applicant:
Hetero Research Foundation
Agent:
Michael Best, Lederer Keller Patentanwälte Partnerschaft mbB
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION IN PROGRESS
EP12766060

INSECTICIDAL 2-METHOXYBENZAMIDE DERIVATIVES

IPC classification:
A01P 9/00, A01P 7/04, A01P 7/02, A01P 5/00, A01N 43/40, C07D 213/82, C07D 213/81
Applicant:
Syngenta Participations AG
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Agent:
Syngenta International AG
Status:
GRANT OF PATENT INTENDED
EP12848616

AN EXTENDED RELEASE FORMULATION OF A DIRECT THROMBIN INHIBITOR

IPC classification:
A61K 31/4965
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
GRANT OF PATENT INTENDED
EP13738230

COMPOSITIONS AND METHODS RELATING TO LYME DISEASE

IPC classification:
G01N 33/68, G01N 33/50, C07K 14/195
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION IN PROGRESS
EP12777436

NEUTRALIZING ANTIBODIES TO NIPAH AND HENDRA VIRUS

IPC classification:
A61K 39/00, C07K 16/10
Applicant:
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Agent:
Fanelli Haag & Kilger PLLC
Status:
APPLICATION WITHDRAWN
EP13723629

PHARMACEUTICAL NANOPARTICLES SHOWING IMPROVED MUCOSAL TRANSPORT

IPC classification:
A61K 47/34, A61K 47/26, A61K 31/56, A61K 9/10, A61K 9/00
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Agent:
Cabinet Regimbeau
Status:
EXAMINATION IN PROGRESS
EP13723350

PHARMACEUTICAL NANOPARTICLES SHOWING IMPROVED MUCOSAL TRANSPORT

IPC classification:
A61K 47/32, A61K 9/51, A61K 9/10
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Agent:
Cabinet Regimbeau
Status:
EXAMINATION IN PROGRESS
EP13724670

PHARMACEUTICAL NANOPARTICLES SHOWING IMPROVED MUCOSAL TRANSPORT

IPC classification:
A61K 47/34, A61K 9/51, A61K 9/10
Applicant:
Johns Hopkins University
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Agent:
Cabinet Regimbeau
Status:
EXAMINATION IN PROGRESS
EP13783039

INSECTICIDAL COMPOUNDS

IPC classification:
C07C 235/64
Applicant:
Syngenta Participations AG
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Agent:
Syngenta International AG
Status:
GRANT OF PATENT INTENDED
EP13855714

GONORRHEAL MTRE PEPTIDES AND VACCINES

IPC classification:
A61K 39/40, A61K 39/00, A61K 38/00
Applicant:
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
GRANT OF PATENT INTENDED
EP13831444

PLACENTAL VACCINATION THERAPY FOR CANCER

IPC classification:
A61K 35/50, C12N 5/073, A61P 37/04, A61P 35/00
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
GRANT OF PATENT INTENDED
EP13865366

SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF

IPC classification:
A61K 31/7052, C07H 19/20, C07H 19/167, A61P 31/14
Agent:
Kristina Cornish, Kilburn & Strode LLP
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Agent:
Plougmann & Vingtoft A/S
Status:
GRANT OF PATENT INTENDED
EP14751929

THERAPEUTIC COMPOUNDS AND USES THEREOF

IPC classification:
C07D 215/233, A61K 31/4709, A61K 31/47
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP14754329

THERAPEUTIC COMPOUNDS AND USES THEREOF

IPC classification:
C07D 215/233
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP14181812

Providing information to a user through somatosensory feedback

IPC classification:
A61F 11/04
Applicant:
Baylor College of Medicine
Applicant:
William Marsh Rice University
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Agent:
Dominic Forsythe, J A Kemp
Status:
EXAMINATION REQUESTED
EP14762750

MEROPENEM DERIVATIVES AND USES THEREOF

IPC classification:
C07D 487/04, C07D 477/20, A61K 31/407
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP14713869

INSECTICIDAL COMPOUNDS

IPC classification:
C07D 213/89, C07D 213/82
Applicant:
Syngenta Participations AG
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Agent:
Syngenta International AG
Status:
EXAMINATION IN PROGRESS
EP14714695

INSECTICIDAL COMPOUNDS

IPC classification:
C07D 213/89, C07D 213/82
Applicant:
Syngenta Participations AG
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Agent:
Syngenta International AG
Status:
EXAMINATION IN PROGRESS
EP14713870

PROCESS FOR THE PREPARATION OF AMIDES FROM HINDERED ANILINES CONTAINING A PERHALOALKYL GROUP

IPC classification:
C07C 253/30, C07C 233/15, C07D 213/81, C07C 255/57
Applicant:
Syngenta Participations AG
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Agent:
Syngenta International AG
Status:
EXAMINATION IN PROGRESS
EP14843298

PYRIDAZINONE COMPOUNDS AND USES THEREOF

IPC classification:
C07D 487/04, C07D 473/00, C07D 471/04, C07D 413/06, C07D 409/12, C07D 409/10, C07D 405/12, C07D 405/10, C07D 405/06, C07D 405/04, C07D 403/12, C07D 403/10, C07D 403/08, C07D 403/06, C07D 403/04, C07D 401/12, C07D 401/10, C07D 401/08, C07D 401/04, C07D 237/24
Agent:
Kristina Cornish, Kilburn & Strode LLP
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Agent:
Hans-Lothar Arth, ABK Patent, Trademark and Design Attorneys
Status:
GRANT OF PATENT INTENDED
EP14844961

AZA-PYRIDONE COMPOUNDS AND USES THEREOF

IPC classification:
A61P 31/16, A61P 31/14, A61K 31/4985, C07D 487/04
Agent:
Kristina Cornish, Kilburn & Strode LLP
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Agent:
Hans-Lothar Arth, ABK Patent, Trademark and Design Attorneys
Status:
GRANT OF PATENT INTENDED
EP14837913

ANTIVIRAL COMPOUNDS

IPC classification:
C07D 491/052, C07D 491/048, C07D 487/04, C07D 471/04, C07D 417/12, C07D 417/06, C07D 417/04, C07D 413/12, C07D 413/04, C07D 409/14, C07D 409/04, C07D 405/12, C07D 401/12, C07D 401/06, C07D 401/04, C07D 277/28, C07D 239/34, C07D 233/58, C07D 213/40, C07D 207/267
Agent:
Kristina Cornish, Kilburn & Strode LLP
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Agent:
Hans-Lothar Arth, ABK Patent, Trademark and Design Attorneys
Status:
GRANT OF PATENT INTENDED
EP14850483

METHOD FOR REVERSING RECENT-ONSET TYPE 1 DIABETES (T1D) BY ADMINISTERING SUBSTANCE P (SP)

IPC classification:
A61P 3/00, A61K 31/165, A61K 31/00
Agent:
Lecomte & Partners Sàrl
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP14857737

CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS AND USES THEREOF

IPC classification:
A01N 43/48
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP14857110

CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS AND USES THEREOF

IPC classification:
A01N 43/54, A61K 31/497
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP14858272

COMPOSITIONS AND METHODS FOR OPHTHALMIC AND/OR OTHER APPLICATIONS

IPC classification:
A61K 31/56
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP14816261

INSECTICIDAL COMPOUNDS

IPC classification:
C07C 237/44, C07C 237/42, A01N 43/00, C07C 255/57
Applicant:
Syngenta Participations AG
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Agent:
Syngenta International AG
Status:
EXAMINATION REQUESTED
EP14815381

INSECTICIDAL COMPOUNDS

IPC classification:
A01N 43/00, C07C 255/57
Applicant:
Syngenta Participations AG
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Agent:
Syngenta International AG
Status:
EXAMINATION REQUESTED
EP15712431

ANTI-LAMININ4 ANTIBODIES SPECIFIC FOR LG1-3

IPC classification:
A61K 39/395, A61P 35/00, G01N 33/53, C07K 16/18
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP15712429

ANTI-MCAM ANTIBODIES AND ASSOCIATED METHODS OF USE

IPC classification:
C07K 16/30
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP15712432

ANTI-LAMININ4 ANTIBODIES SPECIFIC FOR LG4-5

IPC classification:
A61P 3/04, A61P 37/06, A61P 35/00, A61K 39/395, C07K 16/18
Agent:
Roisin McNally, F. R. Kelly & Co.
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP15712195

COMBINATION TREATMENT FOR MULTIPLE SCLEROSIS

IPC classification:
C07K 16/30
Agent:
Giorgio Contadin, Notarbartolo & Gervasi SpA
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP15829485

AUTHENTICATION DEVICES

IPC classification:
G06F 21/00
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP15831866

ZOLEDRONIC ACID DOSAGE FORMS FOR THE TREATMENT OF PAIN

IPC classification:
A61P 19/02, A61P 19/00, A61K 31/197, A61K 31/675
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP15837307

SUBCUTANEOUS WOUND DEBRIDEMENT

IPC classification:
A61B 17/22
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
Request for examination was made
EP15839010

ANTI-PD-L1 CONJUGATES FOR TREATING TUMORS

IPC classification:
A61P 35/00, A61K 45/00, A61K 31/4375, A61K 31/708, A61K 31/4745, C07K 16/30
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
Request for examination was made
EP15844087

MICRORNA BIOMARKERS FOR POSTTRAUMATIC STRESS DISORDER AND METHODS OF USE THEREOF

IPC classification:
C12Q 1/68, C12N 15/09, C12N 15/113
Applicant:
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
Request for examination was made
EP15849413

COMPOSITIONS, PANELS AND SHEETS COMPRISING CELLULOSE FILAMENTS AND GYPSUM AND METHODS FOR PRODUCING THE SAME

IPC classification:
E04C 2/26, C04B 16/02, C04B 11/00, B32B 3/12, B32B 13/02, C04B 28/14
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
Request for examination was made
EP15814003

1 -AMINO-TRIAZOLO(1,5-A)PYRIDINE-SUBSTITUTED UREA DERIVATIVE AND USES THEREOF

IPC classification:
A61K 31/00, C07D 471/04, C07D 403/04, C07D 401/04
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
Request for examination was made
EP17151821

NOVEL POLYMORPHS OF PITAVASTATIN CALCIUM

IPC classification:
A61P 9/10, A61K 31/47, C07D 215/14
Applicant:
Hetero Research Foundation
Agent:
Michael Best, Lederer Keller Patentanwälte Partnerschaft mbB
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
Request for examination was made
EP16713568

IPN VIRUS GENOME MUTATIONS AND CODON INTERACTIONS

IPC classification:
C07K 14/005, A61K 39/00, A61K 39/12, C12N 7/00
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
Request for examination was made
EP15756844

TREATMENT FOR CHITIN-CONTAINING MICOORGANISMS

IPC classification:
A01P 3/00, A01P 1/00, A01N 37/02, A01N 59/14
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
Request for examination was made
EP16812371

METHOD AND SYSTEM FOR SEQUENCING IN CHARACTERIZATION OF ANTIBODY BINDING BEHAVIOR

IPC classification:
A61K 39/00, C12N 9/96, C12P 19/34, C12Q 1/68, G01N 33/532, C07K 16/00
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Agent:
AOMB (Algemeen Octrooi- en Merkenbureau BV)
Status:
Request for examination was made
EP16823606

FILTER MEDIA COMPRISING CELLULOSE FILAMENTS

IPC classification:
B01D 39/16
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
Request for examination was made
EP18155187

INSECTICIDAL COMPOUNDS

IPC classification:
C07D 213/60, C07D 207/34, A01N 37/18, A01N 31/00, C07C 255/57, C07C 237/44
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
The application has been published
EP16778454

BIODEGRADABLE IMPLANT

IPC classification:
A61L 27/58, A61L 27/54, A61L 27/52, A61L 27/20, A61L 27/16
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
Request for examination was made
EP18165200

INSECTICIDAL 2-METHOXYBENZAMIDE DERIVATIVES

IPC classification:
A01P 9/00, A01P 7/04, A01P 7/02, A01P 5/00, A01N 43/40, C07D 213/82, C07D 213/81
Agent:
Syngenta International AG
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
The application has been published
EP16861059

TREATMENT OF CANCER WITH COMBINATIONS OF RXR AGONISTS AND THYROID HORMONES

IPC classification:
C07C 57/50, C07C 57/30, C07C 57/03, A61P 35/00, A61K 45/06
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
Request for examination was made
EP16861057

TREATMENT OF NERVOUS SYSTEM DISORDERS USING THYROID HORMONE NEUTRAL DOSES OF RXR AGONISTS

IPC classification:
A61P 25/16, A61K 45/00, A61K 31/203, A61K 31/192, A61K 31/185, A61P 25/28
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
Request for examination was made
EP16861054

TREATMENT OF NERVOUS SYSTEM DISORDERS USING COMBINATIONS OF RXR AGONISTS AND THYROID HORMONES

IPC classification:
C07C 57/50, C07C 57/30, C07C 57/03, A61P 25/28, A61K 45/06
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
Request for examination was made

Please Sign in to use this feature